Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates

  • Bluebird Bio (BLUE) came out with a quarterly loss of $2.66 per share versus the Zacks Consensus Estimate of a loss of $3.60. This compares to loss of $7.20 per share a year ago.